title: Drug updates and approvals: 2014 in review.
abstract: This article highlights important prescribing information for new drugs approved by the FDA over the last year. These include albiglutide, apremilast, dapagliflozin, insulin human inhalation powder, riociguat, timothy grass pollen allergen extract, umeclidinium and vilanterol inhalation powder, and vorapaxar.
authors.affiliation: Jeff Sigler is the president of SFI Medical Publishing, Lawrence, Kan.
authors.forename: Jeff
authors.initials: J
authors.lastname: Sigler
mesh_terms: D000485:Allergens / Q000627:therapeutic use; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D001592:Benzyl Alcohols / Q000627:therapeutic use; D002722:Chlorobenzenes / Q000627:therapeutic use; D017277:Drug Approval; D058995:Dry Powder Inhalers; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives / Q000627:therapeutic use; D005960:Glucosides / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007783:Lactones / Q000627:therapeutic use; D009722:Nurse Practitioners; D031784:Phleum; D010936:Plant Extracts / Q000627:therapeutic use; D011058:Pollen; D011720:Pyrazoles / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011812:Quinuclidines / Q000627:therapeutic use; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000485:Allergens; D001559:Benzhydryl Compounds; D001592:Benzyl Alcohols; D002722:Chlorobenzenes; C573971:GSK573719; D005960:Glucosides; D007328:Insulin; D007783:Lactones; D010936:Plant Extracts; D011720:Pyrazoles; D011725:Pyridines; D011743:Pyrimidines; D011812:Quinuclidines; C550468:vilanterol; C529054:dapagliflozin; D013792:Thalidomide; C534611:rGLP-1 protein; D052216:Glucagon-Like Peptide 1; C542595:riociguat; C505730:apremilast; C530299:vorapaxar